GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Moderna Inc (MEX:MRNA) » Definitions » Other Long Term Assets

Moderna (MEX:MRNA) Other Long Term Assets : MXN9,186 Mil (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Moderna Other Long Term Assets?

Moderna's other long-term assets for the quarter that ended in Mar. 2025 was MXN9,186 Mil.

Moderna's quarterly other long-term assets declined from Sep. 2024 (MXN10,259 Mil) to Dec. 2024 (MXN10,178 Mil) but then stayed the same from Dec. 2024 (MXN10,178 Mil) to Mar. 2025 (MXN9,186 Mil).

Moderna's annual other long-term assets declined from Dec. 2022 (MXN37,588 Mil) to Dec. 2023 (MXN10,252 Mil) and declined from Dec. 2023 (MXN10,252 Mil) to Dec. 2024 (MXN10,178 Mil).


Moderna Other Long Term Assets Historical Data

The historical data trend for Moderna's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moderna Other Long Term Assets Chart

Moderna Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only 258.60 7,631.21 37,588.29 10,252.45 10,177.58

Moderna Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9,675.62 10,937.10 10,258.65 10,177.58 9,185.73

Moderna Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Moderna Business Description

Address
325 Binney Street, Cambridge, MA, USA, 02139
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.